{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T05:51:03Z","timestamp":1789192263604,"version":"build-2803163510"},"reference-count":19,"publisher":"BMJ","issue":"e1","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J NeuroIntervent Surg"],"accepted":{"date-parts":[[2023,12,3]]},"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Significant controversy exists about the management of unruptured cerebral arteriovenous malformations (AVMs). Results from A Randomized Trial of Unruptured Brain Arteriovenous Malformations (ARUBA) suggested that intervention increases the risk of stroke\/death compared with medical management. However, numerous study limitations raised concerns about the trial\u2019s generalizability.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To assess the rate of stroke\/death and functional outcomes in ARUBA-eligible patients from a multicenter database, the Neurovascular Quality Initiative-Quality Outcomes Database (NVQI-QOD).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We performed a retrospective analysis of prospectively collected data of ARUBA-eligible patients who underwent intervention at 18 participating centers. The primary endpoint was stroke\/death from any cause. Secondary endpoints included neurologic, systemic, radiographic, and functional outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>173 ARUBA-eligible patients underwent intervention with median follow-up of 269 (25\u2013722.5) days. Seventy-five patients received microsurgery\u00b1embolization, 37 received radiosurgery, and 61 received embolization. Baseline demographics, risk factors, and general AVM characteristics were similar between groups. A total of 15 (8.7%) patients experienced stroke\/death with no significant difference in primary outcome between treatment modalities. Microsurgery\u00b1embolization was more likely to achieve AVM obliteration (P&lt;0.001). Kaplan-Meier survival curves demonstrated no difference in overall death\/stroke outcomes between the different treatment modalities' 5-year period (P=0.087). Additionally, when compared with the ARUBA interventional arm, our patients were significantly less likely to experience death\/stroke (8.7% vs 30.7%; P&lt;0.001) and functional impairment (mRS score \u22652 25.4% vs 46.2%; P&lt;0.01).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our results suggest that intervention for unruptured brain AVMs at comprehensive stroke centers across the United States is safe.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/jnis-2023-020525","type":"journal-article","created":{"date-parts":[[2024,1,10]],"date-time":"2024-01-10T01:13:38Z","timestamp":1704849218000},"page":"e1-e8","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":5,"title":["Treatment outcomes for ARUBA-eligible brain arteriovenous malformations: a comparison of real-world data from the NVQI-QOD AVM registry with the ARUBA trial"],"prefix":"10.1136","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7601-6920","authenticated-orcid":false,"given":"Anas","family":"Alrohimi","sequence":"first","affiliation":[{"name":"Cerebrovascular Center, Departments of Neurology and Neurosurgery, Neurological Institute, Cleveland Clinic Foundation, Cleveland, Ohio, USA"},{"name":"Department of Medicine (Neurology), King Saud University, Riyadh, Riyadh Province, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-1362-1944","authenticated-orcid":false,"given":"Rebecca L","family":"Achey","sequence":"additional","affiliation":[{"name":"Cerebrovascular Center, Departments of Neurology and Neurosurgery, Neurological Institute, Cleveland Clinic Foundation, Cleveland, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Thompson","sequence":"additional","affiliation":[{"name":"Department of Quantitative Health Sciences (NRT), Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramez N","family":"Abdalla","sequence":"additional","affiliation":[{"name":"Department of Radiology, Neurology, and Neurological Surgery, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Patterson","sequence":"additional","affiliation":[{"name":"Cerebrovascular Center, Departments of Neurology and Neurosurgery, Neurological Institute, Cleveland Clinic Foundation, Cleveland, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasaman","family":"Moazeni","sequence":"additional","affiliation":[{"name":"Department of Radiology, Neurology, and Neurological Surgery, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A","family":"Rasmussen","sequence":"additional","affiliation":[{"name":"Cerebrovascular Center, Departments of Neurology and Neurosurgery, Neurological Institute, Cleveland Clinic Foundation, Cleveland, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3646-3635","authenticated-orcid":false,"given":"Gabor","family":"Toth","sequence":"additional","affiliation":[{"name":"Cerebrovascular Center, Departments of Neurology and Neurosurgery, Neurological Institute, Cleveland Clinic Foundation, Cleveland, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark D","family":"Bain","sequence":"additional","affiliation":[{"name":"Cerebrovascular Center, Departments of Neurology and Neurosurgery, Neurological Institute, Cleveland Clinic Foundation, Cleveland, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameer A","family":"Ansari","sequence":"additional","affiliation":[{"name":"Department of Radiology, Neurology, and Neurological Surgery, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8506-7743","authenticated-orcid":false,"given":"Shazam M","family":"Hussain","sequence":"additional","affiliation":[{"name":"Cerebrovascular Center, Departments of Neurology and Neurosurgery, Neurological Institute, Cleveland Clinic Foundation, Cleveland, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina Z","family":"Moore","sequence":"additional","affiliation":[{"name":"Cerebrovascular Center, Departments of Neurology and Neurosurgery, Neurological Institute, Cleveland Clinic Foundation, Cleveland, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,1,9]]},"reference":[{"key":"2025092911253413000_17.e1.e1.1","doi-asserted-by":"publisher","DOI":"10.3171\/jns.1988.68.3.0352"},{"key":"2025092911253413000_17.e1.e1.2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.49.1.1"},{"key":"2025092911253413000_17.e1.e1.3","doi-asserted-by":"publisher","DOI":"10.3171\/jns.1972.37.5.0562"},{"key":"2025092911253413000_17.e1.e1.4","doi-asserted-by":"publisher","DOI":"10.1227\/00006123-198411000-00003"},{"key":"2025092911253413000_17.e1.e1.5","doi-asserted-by":"publisher","DOI":"10.3171\/jns.1983.58.3.0331"},{"key":"2025092911253413000_17.e1.e1.6","doi-asserted-by":"publisher","DOI":"10.1097\/00006123-198911000-00019"},{"key":"2025092911253413000_17.e1.e1.7","doi-asserted-by":"publisher","DOI":"10.3171\/jns.1990.73.3.0387"},{"key":"2025092911253413000_17.e1.e1.8","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)62302-8"},{"key":"2025092911253413000_17.e1.e1.9","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S1474-4422(20)30181-2","article-title":"Medical management with Interventional therapy versus medical management alone for unruptured brain arteriovenous malformations (ARUBA): final follow-up of a multicentre, non-blinded, randomised controlled trial","volume":"19","author":"Mohr","year":"2020","journal-title":"The Lancet Neurology"},{"key":"2025092911253413000_17.e1.e1.10","doi-asserted-by":"crossref","unstructured":"Rutledge WC , Abla AA , Nelson J , et al . Treatment and outcomes of ARUBA-eligible patients with unruptured brain arteriovenous malformations at a single institution. Neurosurg Focus 2014;37. doi:10.3171\/2014.7.FOCUS14242","DOI":"10.3171\/2014.7.FOCUS14242"},{"key":"2025092911253413000_17.e1.e1.11","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1093\/neuros\/nyx506","article-title":"Treatment outcomes of a randomized trial of unruptured brain arteriovenous malformation-eligible unruptured brain arteriovenous malformation patients","volume":"83","author":"Lang","year":"2018","journal-title":"Neurosurgery"},{"key":"2025092911253413000_17.e1.e1.12","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.115.011400"},{"key":"2025092911253413000_17.e1.e1.13","doi-asserted-by":"publisher","DOI":"10.1080\/02688697.2016.1181153"},{"key":"2025092911253413000_17.e1.e1.14","doi-asserted-by":"publisher","DOI":"10.1227\/NEU.0000000000000663"},{"key":"2025092911253413000_17.e1.e1.15","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.116.014660"},{"key":"2025092911253413000_17.e1.e1.16","doi-asserted-by":"crossref","unstructured":"Dicpinigaitis AJ , Ogulnick JV , Mayer SA , et al . Increase in ruptured cerebral arteriovenous malformations and mortality in the United States: unintended consequences of the ARUBA trial? Stroke: Vascular and Interventional Neurology 2023;3. doi:10.1161\/SVIN.122.000700","DOI":"10.1161\/SVIN.122.000700"},{"key":"2025092911253413000_17.e1.e1.17","doi-asserted-by":"publisher","DOI":"10.1136\/jnis-2022-019110"},{"key":"2025092911253413000_17.e1.e1.18","doi-asserted-by":"crossref","unstructured":"Ramsay IA , Govindarajan V , Elarjani T , et al . Impact of COVID-19 pandemic on treatment and outcomes of cerebral arteriovenous malformations. J Neurointerv Surg 2023. doi:10.1136\/jnis-2023-020735","DOI":"10.1136\/jnis-2023-020735"},{"key":"2025092911253413000_17.e1.e1.19","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1227\/neu.0000000000002115","article-title":"Stereotactic radiosurgery for a randomized trial of unruptured brain arteriovenous malformations-eligible patients: a meta-analysis","volume":"91","author":"Ilyas","year":"2022","journal-title":"Neurosurgery"}],"container-title":["Journal of NeuroInterventional Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jnis-2023-020525","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T18:25:47Z","timestamp":1759170347000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnis.bmj.com\/lookup\/doi\/10.1136\/jnis-2023-020525"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,9]]},"references-count":19,"journal-issue":{"issue":"e1","published-online":{"date-parts":[[2024,12,26]]},"published-print":{"date-parts":[[2025,1]]}},"alternative-id":["10.1136\/jnis-2023-020525"],"URL":"https:\/\/doi.org\/10.1136\/jnis-2023-020525","relation":{},"ISSN":["1759-8478","1759-8486"],"issn-type":[{"value":"1759-8478","type":"print"},{"value":"1759-8486","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,9]]}}}